A Bayesian Reanalysis of a Trial of Psilocybin versus Escitalopram for Depression
{{output}}
Objectives: To perform a Bayesian reanalysis of a recent trial of psilocybin (COMP360) versus escitalopram for Major Depressive Disorder (MDD) in order to provide a more informative interpretation of the indeterminate outcome of ... ...
